Circulating tumor (ct)DNA monitoring of ER+/HER2- high-risk breast cancer during adjuvant endocrine therapy Published Date August 26, 2025 Pusztai et al, ASCO 2025 Expand Fullscreen Exit Fullscreen Download PDF Expand Fullscreen
